Headquartered in New York,
Avon Products ( ) is the world's largest direct seller with about 6 million active independent sales representatives. Avon products include color cosmetics, skincare, fragrance, fashion and home products, under brand names like Avon Color, ANEW, Skin-So-Soft and Advance Techniques. AVP
In March last year, Avon split into two companies--Avon Products, a publicly traded company that operates in approximately 70 countries and New Avon LLC, a privately-held company owned by Cerberus Capital Management, and operating in the US, Puerto Rico and Canada.
The company reported adjusted earnings of $0.01 per share for Q4 missing the Zacks Consensus Estimate of $0.09. Revenues fell 2% year over year and were also short of the Zacks Consensus Estimate.
The miss was attributed to a decrease in the number of selling representatives and currency headwinds.
Update on Transformation Plan
The company also provided an update on the Transformation Plan, which was initiated in January 2016, and aims to achieve its long-term goal of a targeted low double-digit operating margin and mid single-digit constant-dollar revenue growth. The plan focuses on investing in growth, reducing costs and improving financial resilience.
Analysts have been slashing their estimates after lackluster results. Zacks Consensus Estimates for the current and nest year have fallen to $0.28 per share and $0.36 per share, down from $0.37 and $0.50, before the results.
The company has missed in three out of last four quarters with an average negative quarterly surprise of about 109%.
The following chart shows the negative earnings and price momentum for AVP:
Better Play in the Industry?
Cosmetics industry is currently ranked 188 out of 265 Zacks industries (bottom 29%). Investors should avoid the industry as of now.
The Bottom Line
In view of the ongoing execution of its turnover plan, the outlook for the company remains cloudy. It remains to be seen whether the company will be able to successfully execute its restructuring plan.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains.
Click to see them right now >>